Jenburkt Pharmaceuticals has been awarded an NSIC-CRISIL rating of -- NSIC-CRISIL SE-1A. The rating indicates highest performance capability and high financial strength and it is valid till June 29, 2012. The company has been rated under the same category for the fourth year in continuation.
Recently, the company was bestowed with ‘National Award for Excellence in Cost Management-2010’ as the first awardee under the category of the ‘Private Manufacturing-(small)’ by the Institute of Cost and Works Accountants of India (ICWAI), which is a statutory body under an act of parliament, at the 8th national award function held at Vigyan Bhawan, New Delhi, on July 18, 2011.
Jenburkt Pharmaceuticals is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.
